ReviewNeuroradiology2025
Review of 7T MRI imaging of pituitary microadenomas: are we there yet?
Review in Neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Functional pituitary adenoma imaging.Reviews in endocrine & metabolic disorders · 2026Review
- Ultra-high-field 7-Tesla MRI in neuro-oncology: a narrative review of current applications and future directions.Quantitative imaging in medicine and surgery · 2026Review
- Acromegaly diagnosis.The Journal of clinical endocrinology and metabolism · 2026Review
- Comparative evaluation of dynamic susceptibility contrast MRI techniques for brain imaging at 3T and 5T magnetic field strengths.Frontiers in human neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purpose7T MRI imaging of the pituitary gland is an emerging technique. The purpose of this article is to review the current status of the 7T MRI of the pituitary gland, particularly in the context of pituitary microadenoma pathology. We will discuss technical challenges and parallel transmission opportunities.
methodsFollow-up study selection and data extraction were performed following PRISMA guidelines. We focused on diagnostic performance and acquisition protocols. Inclusion criteria were: MRI imaging studies of pituitary adenoma at 7T. Exclusion criteria were: Case reports and reviews; studies which did not report MRI protocols; surgical planning studies; studies focusing exclusively on macroadenomas for which ultra-high magnetic field imaging is less decisive than microadenomas in clinical practice.
resultsSix studies were included. 7T MRI outperformed 1.5 or 3T MRI for the detection of microadenomas. Acquisition protocols employed were heterogeneous, with two-dimensional T
conclusion7T MRI is a promising tool for overcoming the difficulties encountered by conventional MRI, particularly in the case of Cushing disease. However, there is insufficient data to precisely define an optimal protocol yet.
Indexed as
Identifiers
40056182What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.